Dr. Richard Isaacson, United States
November 05, 2021
What are the advantages and limitations of the Columbia Suicide Severity Rating Scale in Alzheimer's disease clinical trials? Watch Dr. Richard Isaacson discuss the C-SSRS.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.